Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$4.97 - $7.41 $243 - $363
-49 Reduced 0.35%
14,104 $89,000
Q3 2023

Oct 24, 2023

SELL
$6.24 - $15.91 $43 - $111
-7 Reduced 0.05%
14,153 $92,000
Q2 2023

Jul 25, 2023

SELL
$5.43 - $21.51 $25,521 - $101,097
-4,700 Reduced 24.92%
14,160 $219,000
Q1 2023

Apr 14, 2023

BUY
$5.64 - $9.89 $106,370 - $186,525
18,860 New
18,860 $108,000
Q3 2021

Nov 02, 2021

SELL
$21.43 - $32.05 $149,945 - $224,253
-6,997 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$19.8 - $48.55 $111,375 - $273,093
-5,625 Reduced 44.57%
6,997 $224,000
Q1 2021

May 14, 2021

BUY
$36.41 - $89.39 $459,567 - $1.13 Million
12,622 New
12,622 $523,000

Others Institutions Holding NNOX

About Nano-X Imaging Ltd.


  • Ticker NNOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,214,700
  • Market Cap $383M
  • Description
  • Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode....
More about NNOX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.